AAAAAA

   
Results: 1-8 |
Results: 8
Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists
Authors: Harada, H Kazami, J Watanuki, S Tsuzuki, R Sudoh, K Fujimori, A Sanagi, M Orita, M Nakahara, H Shimaya, J Tsukamoto, S Tanaka, A Yanagisawa, I
Citation: H. Harada et al., Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists, BIO MED CH, 9(11), 2001, pp. 2955-2968
Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload
Authors: Tokioka-Akagi, T Fujimori, A Shibasaki, M Inagaki, O Yanagisawa, I
Citation: T. Tokioka-akagi et al., Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload, JPN J PHARM, 86(1), 2001, pp. 79-85
Ethenesulfonamide derivatives, a novel class of orally active endothelin-Areceptor antagonists
Authors: Harada, H Kazami, J Watanuki, S Tsuzuki, R Sudoh, K Fujimori, A Tanaka, A Tsukamoto, S Yanagisawa, I
Citation: H. Harada et al., Ethenesulfonamide derivatives, a novel class of orally active endothelin-Areceptor antagonists, CHEM PHARM, 49(5), 2001, pp. 606-612
Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists
Authors: Harada, H Kazami, J Watanuki, S Tsuzuki, R Sudoh, K Fujimori, A Tokunaga, T Tanaka, A Tsukamoto, S Yanagisawa, I
Citation: H. Harada et al., Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists, CHEM PHARM, 49(12), 2001, pp. 1593-1603
Novel potassium channel openers. Part 4: Transformation of the 1,4-benzoxazine skeleton into 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine
Authors: Matsumoto, Y Tsuzuki, R Matsuhisa, A Yoden, T Yamagiwa, Y Yanagisawa, I Shibanuma, T Nohira, H
Citation: Y. Matsumoto et al., Novel potassium channel openers. Part 4: Transformation of the 1,4-benzoxazine skeleton into 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine, BIO MED CH, 8(2), 2000, pp. 393-404
Effects of YM358, an angiotensin II type 1 (AT(1)) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models
Authors: Tokioka, T Shibasaki, M Fujimori, A Matsuda-Satoh, Y Uchida, W Inagaki, O Yanagisawa, I
Citation: T. Tokioka et al., Effects of YM358, an angiotensin II type 1 (AT(1)) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models, BIOL PHAR B, 23(2), 2000, pp. 174-181
Novel potassium channel activators. III. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: Modification at the 2 position
Authors: Matsumoto, Y Uchida, W Nakahara, H Yanagisawa, I Shibanuma, T Nohira, H
Citation: Y. Matsumoto et al., Novel potassium channel activators. III. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: Modification at the 2 position, CHEM PHARM, 48(3), 2000, pp. 428-432
Novel potassium channel activators. II. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: Modification of the aromatic part
Authors: Matsumoto, Y Tsuzuki, R Matsuhisa, A Masuda, N Yamagiwa, Y Yanagisawa, I Shibanuma, T Nohira, H
Citation: Y. Matsumoto et al., Novel potassium channel activators. II. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: Modification of the aromatic part, CHEM PHARM, 47(7), 1999, pp. 971-979
Risultati: 1-8 |